+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Virtual Clinical Trials Market by Study Design (Expanded Access Trials, Interventional Trials, Observational Trials), Implication (Cardiovascular Disease, Oncology) - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5305495
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Virtual Clinical Trials Market size was estimated at USD 3.81 billion in 2023, USD 4.66 billion in 2024, and is expected to grow at a CAGR of 22.44% to reach USD 15.72 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Virtual Clinical Trials Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Virtual Clinical Trials Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Virtual Clinical Trials Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Clinical Ink, Inc. by GI Partners, CliniOps, Inc, Everest Global, Inc, ICON PLC, IQVIA Inc., Medable, Inc., Medidata Solutions by Dassault Systèmes S.E., Medpace, Inc., MedPoint Digital, Inc., Navitas Inc., Oracle Corporation, Parexel International Corporation, Pfizer Inc., and VirTrial, LLC by Signant Health.

Market Segmentation & Coverage

This research report categorizes the Virtual Clinical Trials Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Study Design
    • Expanded Access Trials
    • Interventional Trials
    • Observational Trials
  • Implication
    • Cardiovascular Disease
    • Oncology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Virtual Clinical Trials Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Virtual Clinical Trials Market?
  3. What are the technology trends and regulatory frameworks in the Virtual Clinical Trials Market?
  4. What is the market share of the leading vendors in the Virtual Clinical Trials Market?
  5. Which modes and strategic moves are suitable for entering the Virtual Clinical Trials Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Virtual Clinical Trials Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing adoption of telehealth
5.1.1.2. Growing adoption of digitization in healthcare sector globally
5.1.1.3. Proliferation in research and development activities coupled with favorable government support
5.1.2. Restraints
5.1.2.1. Concerns over large data collection, data accuracy and reliability, and technological failure
5.1.3. Opportunities
5.1.3.1. Integration of new technologies in clinical trials
5.1.3.2. Emerging collaborations between software, biotechnology and clinical research companies
5.1.4. Challenges
5.1.4.1. Cumbersome and difficult process with enrolment and engagement activities
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Virtual Clinical Trials Market, by Study Design
6.1. Introduction
6.2. Expanded Access Trials
6.3. Interventional Trials
6.4. Observational Trials
7. Virtual Clinical Trials Market, by Implication
7.1. Introduction
7.2. Cardiovascular Disease
7.3. Oncology
8. Americas Virtual Clinical Trials Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Virtual Clinical Trials Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Virtual Clinical Trials Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. AiCure, LLC
12.1.2. Clinical Ink, Inc. by GI Partners
12.1.3. CliniOps, Inc
12.1.4. Everest Global, Inc
12.1.5. ICON PLC
12.1.6. IQVIA Inc.
12.1.7. Medable, Inc.
12.1.8. Medidata Solutions by Dassault Systèmes S.E.
12.1.9. Medpace, Inc.
12.1.10. MedPoint Digital, Inc.
12.1.11. Navitas Inc.
12.1.12. Oracle Corporation
12.1.13. Parexel International Corporation
12.1.14. Pfizer Inc.
12.1.15. VirTrial, LLC by Signant Health
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. VIRTUAL CLINICAL TRIALS MARKET RESEARCH PROCESS
FIGURE 2. VIRTUAL CLINICAL TRIALS MARKET SIZE, 2023 VS 2030
FIGURE 3. VIRTUAL CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. VIRTUAL CLINICAL TRIALS MARKET DYNAMICS
FIGURE 7. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2023 VS 2030 (%)
FIGURE 8. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2023 VS 2030 (%)
FIGURE 10. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. VIRTUAL CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. VIRTUAL CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. VIRTUAL CLINICAL TRIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. VIRTUAL CLINICAL TRIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 6. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY EXPANDED ACCESS TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY INTERVENTIONAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL TRIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 10. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. VIRTUAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 13. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 15. ARGENTINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 16. ARGENTINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 17. BRAZIL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 18. BRAZIL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 19. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 20. CANADA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 21. MEXICO VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 22. MEXICO VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 27. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. AUSTRALIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 30. AUSTRALIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 31. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 32. CHINA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 33. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 34. INDIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 35. INDONESIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 36. INDONESIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 37. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 38. JAPAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 39. MALAYSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 40. MALAYSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 41. PHILIPPINES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 42. PHILIPPINES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 43. SINGAPORE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 44. SINGAPORE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 45. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 46. SOUTH KOREA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 47. TAIWAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 48. TAIWAN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 49. THAILAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 50. THAILAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 51. VIETNAM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 52. VIETNAM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 53. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. DENMARK VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 57. DENMARK VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 58. EGYPT VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 59. EGYPT VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 60. FINLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 61. FINLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 62. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 63. FRANCE VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 64. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 65. GERMANY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 68. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 69. ITALY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 70. NETHERLANDS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 71. NETHERLANDS VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 72. NIGERIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 73. NIGERIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 74. NORWAY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 75. NORWAY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 76. POLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 77. POLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 78. QATAR VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 79. QATAR VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 82. SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 83. SAUDI ARABIA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 85. SOUTH AFRICA VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 86. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 87. SPAIN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SWEDEN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 89. SWEDEN VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 90. SWITZERLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 91. SWITZERLAND VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TURKEY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 93. TURKEY VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 94. UNITED ARAB EMIRATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY STUDY DESIGN, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM VIRTUAL CLINICAL TRIALS MARKET SIZE, BY IMPLICATION, 2018-2030 (USD MILLION)
TABLE 98. VIRTUAL CLINICAL TRIALS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 99. VIRTUAL CLINICAL TRIALS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 100. VIRTUAL CLINICAL TRIALS MARKET LICENSE & PRICING

Companies Mentioned

  • AiCure, LLC
  • Clinical Ink, Inc. by GI Partners
  • CliniOps, Inc
  • Everest Global, Inc
  • ICON PLC
  • IQVIA Inc.
  • Medable, Inc.
  • Medidata Solutions by Dassault Systèmes S.E.
  • Medpace, Inc.
  • MedPoint Digital, Inc.
  • Navitas Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Pfizer Inc.
  • VirTrial, LLC by Signant Health

Methodology

Loading
LOADING...

Table Information